Guidance on the Biocidal Products Regulation

Total Page:16

File Type:pdf, Size:1020Kb

Guidance on the Biocidal Products Regulation SUPERSEDED GUIDANCE - NEWER VERSION AVAILA BLE Guidance on the Biocidal Products Regulation Volume II Efficacy - Assessment and Evaluation (Parts B+C) Version 2.0 December 2017 Guidance on the BPR: Volume II Parts B+C 2 Version 2.0 December 2017 LEGAL NOTICE This document aims to assist users in complying with their obligations under the Biocidal Products Regulation (BPR). However, users are reminded that the text of the BPR is the only authentic legal reference and that the information in this document does not constitute legal advice. Usage of the information remains under the sole responsibility of the user. The European Chemicals Agency does not accept any liability with regard to the use that may be made of the information contained in this document. Guidance on the BPR: Volume II Efficacy - Assessment and Evaluation (Parts B+C) Reference: ECHA-17-G-28-EN Cat. Number: ED-07-17-062-EN-N ISBN: 978-92-9020-259-2 DoI: 10.2823/532500 Publ.date: December 2017 Language: EN © European Chemicals Agency, 2017 If you have questions or comments in relation to this document please send them (quote the reference and issue date) using the information request form. The information request form can be accessed via the Contact ECHA page at: http://echa.europa.eu/contact. European Chemicals Agency Mailing address: P.O. Box 400, FI-00121 Helsinki, Finland Visiting address: Annankatu 18, Helsinki, Finland Guidance on the BPR: Volume II Parts B+C Version 2.0 December 2017 3 DOCUMENT HISTORY Version Comment Date Version 1.0 First edition February 2017 Version 2.0 Update to PT8 December 2017 The text has been revised as follows: To add a new Appendix 12; To revise section 5.5.8.3 to remove temporary footnote re. the new Appendix 12; To add a new footnote to section 5.5.8.2.2.3, Use Class 2, Test Species; To re-number Appendices after the new Appendix 12 and revise all cross references to these Appendices. Guidance on the BPR: Volume II Parts B+C 4 Version 2.0 December 2017 PREFACE The Guidance on the Biocidal Products Regulation (BPR) is to be applied to applications for active substance approval and product authorisation as submitted from 1 September 2013, the date of application (DoA) of the Biocidal Product Regulation (the BPR). This document describes the BPR obligations and how to fulfil them. The scientific guidance provides technical scientific advice on how to fulfil the information requirements set by the BPR (Part A), how to perform the risk assessment and the exposure assessment for the evaluation of the human health and environmental aspects and how to asses and evaluate the efficacy to establish the benefit arising from the use of biocidal products and that it is sufficiently effective (Parts B & C). In addition to the BPR guidance, the Biocidal Products Directive (BPD) guidance and other related documents are still considered applicable for new submissions under the BPR in the areas where the BPR guidance is under preparation. Furthermore these documents are still valid in relation to the applications for active substance approval or applications for product authorisation under the BPD that may still be under evaluation. Also the Commission has addressed some of the obligations in further detail in the Biocides competent authorities meetings documents which applicants are advised to consult. Please see ECHA Biocides Guidance website for links to these documents: [https://echa.europa.eu/guidance- documents/guidance-on-biocides-legislation]. Applicability of Guidance Guidance on applicability of new guidance or guidance related documents for active substance approval is given in the published document “Applicability time of new guidance and guidance-related documents in active substance approval” available on the BPC Webpage1 [https://echa.europa.eu/about-us/who-we-are/biocidal-products-committee] and for applicability of guidance for product authorisation, please see the CA-document CA- july2012-doc6.2d (final), available on the ECHA Guidance page [https://echa.europa.eu/documents/10162/23036409/ca-july12-doc_6_2d_final_en.pdf]. 1 Link available under Working Procedures (right column) [https://echa.europa.eu/about-us/who-we- are/biocidal-products-committee] Guidance on the BPR: Volume II Parts B+C Version 2.0 December 2017 5 Table of Contents LEGAL NOTICE .................................................................................................. 2 DOCUMENT HISTORY ......................................................................................... 3 PREFACE .......................................................................................................... 4 LIST OF ABBREVIATIONS ................................................................................... 16 GLOSSARY OF TERMS ........................................................................................ 18 1. GENERAL INTRODUCTION ............................................................................... 22 2. CLAIMS ........................................................................................................ 22 2.1 INTRODUCTION ....................................................................................... 22 2.2 LABEL CLAIMS AND DIRECTIONS FOR USE .................................................. 23 3. GENERAL CONSIDERATIONS FOR THE DEVELOPMENT AND REPORTING OF EFFICACY DATA 24 3.1 EFFICACY ................................................................................................ 24 3.1.1 Efficacy tests .................................................................................. 24 3.1.2 Test report ..................................................................................... 25 3.2 RESISTANCE ........................................................................................... 26 4. ACTIVE SUBSTANCE APPROVAL ....................................................................... 26 4.1 INTRODUCTION ....................................................................................... 26 4.2 GENERAL PRINCIPLES .............................................................................. 27 4.2.1 Intended use .................................................................................. 27 4.2.2 Evaluation of efficacy ....................................................................... 27 4.2.2.1 Active substance efficacy (part A): .......................................... 27 4.2.2.2 Product efficacy (part B): ....................................................... 29 4.2.3 Overall evaluation for active substance approval ................................. 29 4.2.4 Link to risk assessment .................................................................... 29 4.3 ACTIVE SUBSTANCES WHICH ARE NOT INTENDED TO BE USED IN ISOLATION 30 4.4 “DUMMY PRODUCTS” ................................................................................ 31 4.5 ACTIVE SUBSTANCES USED IN TREATED MATERIALS AND TREATED ARTICLES 31 4.5.1 Efficacy assessment for active substance approval ............................... 31 4.5.2 Efficacy assessment for active substances in specific PTs ...................... 31 5. PRODUCT AUTHORISATION............................................................................. 33 5.1 EVALUATION OF EFFICACY AT PRODUCT AUTHORISATION STAGE ................. 33 5.2 PRODUCT FAMILIES ................................................................................. 33 5.2.1 Background .................................................................................... 33 5.2.2 Worst case testing ........................................................................... 34 5.2.3 Take formulation types and chemical composition into account ............. 37 5.2.4 Allowing for the addition of new products in a family ............................ 38 5.2.5 Deviation in meta SPC’s ................................................................... 39 5.2.6 Minimum concentration needed ......................................................... 40 5.3 TREATED ARTICLES .................................................................................. 40 5.3.1 The basic distinction between material protection and protection of humans or animals ........................................................................................ 42 Guidance on the BPR: Volume II Parts B+C 6 Version 2.0 December 2017 5.4 DISINFECTANTS (MAIN GROUP 1) .............................................................. 44 5.4.0 General .......................................................................................... 44 5.4.0.1 Introduction ......................................................................... 44 5.4.0.2 Dossier requirements ............................................................ 45 5.4.0.3 Label claim .......................................................................... 45 5.4.0.3.1 Target Organisms .................................................... 46 5.4.0.3.2 Areas of Use ............................................................ 47 5.4.0.3.3 Sites of Application ................................................... 47 5.4.0.3.4 Directions for use (Methods of application) .................. 48 5.4.0.3.5 Other interfering parameters ..................................... 48 5.4.0.4 Efficacy testing ..................................................................... 48 5.4.0.4.1 Tiered approach ....................................................... 48 5.4.0.4.2 Standard test methods ............................................. 50 5.4.0.4.3 Data requirements ..................................................
Recommended publications
  • Society Responds to Contamination …</Italic>: Changes in Pest
    Society responds to contamination . Changes in pest control practices reduce toll on wildlife Daniel W. Anderson ... All this beauty of life is fading year by year, ...fa ding like the glow of a sunset, ...fo undering in the grossness of modern refinement. - John Muir, 1868 While biocides, or pesticides, are designed to kill agricultural pests, many of these toxicants have the unintended effect of depleting natural biodiversity. Determining the specific effect of a biocide on biodiversity is com- plicated because other factors, such as direct habitat loss, also decrease biodiversity. Both in California and nationwide, farmers The agricultural spraying of toxaphene pesticide near wildlife habitat in 1971. Tox- have been among the first bio- aphene has been replaced with more effective and safer pest-control agents. cide-users to respond to the chal- lenge of reducing unintentional contamination of the environment. As a result, today agriculture faces fter direct habitat loss and degra- Twenty years ago, it looked as if many fewer biocide-diversity con- dation, toxic environmental con- biocide use, mostly from agricultural flicts than it did even a decade taminants pose the greatest challenges and public health pest control opera- ago. Changes in use of biocides for conservation. Toxicants, whether tions, was going to be a major continu- have led to recoveries of many antibiotics or biocides, dry-cleaning ing cause of wildlife extirpations at in- previously affected populations solvents or naturally occurring ex- creasing and unprecedented rates. But of birds, which are perhaps the cesses of selenium, are any substances today the picture is brighter due to ex- most studied aspects of bio- capable of destroying living organ- tensive research on how biocides affect diversity in these situations.
    [Show full text]
  • An Independent Contract Research Organisation Specialising in Agrochemical, Biocide, Bio-Pesticide and Seed Product Evaluation
    Expert services delivering competitive advantage An independent Contract Research Organisation specialising in agrochemical, biocide, bio-pesticide and seed product evaluation SynTech Research UK range of services include: As part of the EU/Global organisation Program design, planning and project management Laboratory and field ecotoxicology trials Development, evaluation and enhanced target Analytical studies research trials (GEP) Preparation and delivery of biological assess- Environmental fate studies (GLP) ment dossiers and regulatory submissions Crop variety, bio-stimulant and trait evaluation Provision of data summaries and recommendations HQ and Lab services Main sites Associations Contact: Mr Jerry Calloway, UK Managing Director UK HQ +44 (0) 1359 231 732 [email protected] www.syntechresearch.com Program Design and Management Working closely with clients to plan & design the field program and protocols to their objectives and the needs of regulatory authorities Study Monitoring and Direction through experienced multi-disciplined Project Managers Efficacy and Environmental Fate trials Field and Glasshouse characterisation of product performance (GEP) and environmental fate (GLP) Cereal, OSR, potato, pulses, grass, vegetables and top fruit crop coverage (field and protected) Fungicide, herbicide, insecticide, nematicide, plant growth regulator, bio-stimulant, fertiliser & nutrient, adjuvant and safener product testing Early screening through to development and registration; routine efficacy testing and special
    [Show full text]
  • US EPA, Pesticide Product Label, ELECTRO-BIOCIDE,04/21/2020
    UNITED STATES ENVIRONMENTAL PROTECTION AGENCY WASHINGTON, DC 20460 OFFICE OF CHEMICAL SAFETY AND POLLUTION PREVENTION April 21, 2020 David Swain Authorized Agent for Strategic Resource Optimization, Inc. Scientific & Regulatory Consultants, Inc. 201 W. Van Buren Street Columbia City, Indiana 46725 Subject: Label Amendment: Emerging Viral Pathogens Claim Product Name: ELECTRO-BIOCIDE EPA Registration Number: 87492-1 Application Date: March 20, 2020 Decision Number: 561528 Dear Mr. Swain: The amended label referred to above, submitted in connection with registration under the Federal Insecticide, Fungicide and Rodenticide Act, as amended, is acceptable. This approval does not affect any conditions that were previously imposed on this registration. You continue to be subject to existing conditions on your registration and any deadlines connected with them. A stamped copy of your labeling is enclosed for your records. This labeling supersedes all previously accepted labeling. You must submit one copy of the final printed labeling before you release the product for shipment with the new labeling. In accordance with 40 CFR 152.130(c), you may distribute or sell this product under the previously approved labeling for 18 months from the date of this letter. After 18 months, you may only distribute or sell this product if it bears this new revised labeling or subsequently approved labeling. “To distribute or sell” is defined under FIFRA section 2(gg) and its implementing regulation at 40 CFR 152.3. Because you have opted to add statements pertaining to emerging viral pathogens to your label as described in the August 19, 2016, Guidance to Registrants: Process For Making Claims Against Emerging Viral Pathogens Not On EPA-Registered Disinfectant Labels (“Guidance”), https://www.epa.gov/sites/production/files/2016- 09/documents/emerging_viral_pathogen_program_guidance_final_8_19_16_001_0.pdf, you are subject to the following additional terms of registration: 1.
    [Show full text]
  • Transitional Guidance on the Biocidal Products Regulation
    SUPERSEDED GUIDANCE - NEWER VERSION AVAILA BLE Transitional Guidance on the Biocidal Products Regulation Transitional Guidance on Efficacy Assessment for Product Type 18, Insecticide, Acaricides & other Biocidal Products against Arthropods and Product Type 19, Repellents & Attractants September 2016 TRANSITIONAL GUIDANCE Transitional Guidance on PT18 + PT19 2 September 2016 LEGAL NOTICE This document aims to assist users in complying with their obligations under the Biocidal Products Regulation (BPR). However, users are reminded that the text of the BPR is the only authentic legal reference and that the information in this document does not constitute legal advice. Usage of the information remains under the sole responsibility of the user. The European Chemicals Agency does not accept any liability with regard to the use that may be made of the information contained in this document. Transitional Guidance on Efficacy Assessment for Product Type 18 Insecticide, Acaricides & other Biocidal Products against Arthropods and Product Type 19 Repellents & Attractants. Publ.date: September 2016 Language: EN © European Chemicals Agency, 2016 If you have questions or comments in relation to this document please send them (indicating the document reference, issue date, chapter and/or page of the document which your comment refers) using the Guidance feedback form. The feedback form can be accessed via the ECHA website or directly via the following link: https://comments.echa.europa.eu/comments_cms/FeedbackGuidance.aspx European Chemicals Agency Mailing address: P.O. Box 400, FI-00121 Helsinki, Finland Visiting address: Annankatu 18, Helsinki, Finland Transitional Guidance on PT18 + PT19 3 September 2016 PREFACE This Transitional Guidance is to be applied to applications for active substance approval and product authorisation submitted under the Biocidal Product Regulation (EU) No 528/2012 (the BPR).
    [Show full text]
  • Biocide Standards Reference Guide
    Biocide Standards Reference Guide Main Group I: Main Group II: Disinfectants & Preservatives General Biocidal Products Main Group III: Main Group IV: Pest Control Other Biocidal Products AccuStandard® A biocide can be defined as a chemical or micro-organism which prevents, controls and/or renders harmless organisms through chemical or biological means. Biocides are used wherever organisms may cause product contamination or a health threat to people and/or animals. Biocides can be added to other materials to protect them against biological growth or infestation. “Treated articles” are included within the biocides regulations and are subject to the same requirements as biocides. Biocides are used by workers in all types of industries to control viruses, bacteria, fungi, insects and animals. The intended use and chemical potency of biocides require that their use, storage and disposal be controlled to prevent adverse effects to the public and/or environment. To ensure the safety of biocides, government regulations are in place to assess the active substances within commercial products. One such regulation is the Biological Products Directive 98/8/EC (BPD) which has been recently revised and is now designated as EU Biocides Regulation 528/2012 (EU BPR). Under this legislation, active compounds are submitted for approval on the list of Approved Active Substances. This regulation went into effect in September 2013, and classifies biocides into 22 biocide product types, grouped into four main areas. Biological Products Directive 98/8/EC (BPD) revised 2012 Biocides Main Group I Main Group II Disinfectants and Preservatives general biocidal products Product Type Product Type 6. In-can preservatives 1.
    [Show full text]
  • Sustainable Use of Rodenticides As Biocides in the EU
    Sustainable use of rodenticides as biocides in the EU EuropeanEBPF Biocidal Products Forum Contents 1. Sustainable Use of Biocides 2. The Need for Rodent Control Using Rodenticides (BPD PT 14) in the EU 3. Rodenticide Use Scenarios 4. Types of Rodenticide User 5. Rodenticide Active Substances 6. Environmental Impacts of Anticoagulant Rodenticides 7. Alternative Rodent Control Techniques 8. Anticoagulant Resistance 9. IPM in Rodent Pest Management 10. Regulatory Review of Rodenticides and Label Instructions 11. Best Practice Guidelines 12. Cross-over Products 13. Training of Rodenticide Users 14. Current PT 14 Sustainable/Responsible Use Initiatives 15. Recommendations for Sustainable Use of Rodenticides in the EU The European Biocidal Products Forum – spokesman for the European biocides industry Concerned with many aspects of the biocide rugulatory regime currently in place in Europe, Cefic has set up an industry platform where all industry stakeholders involved in the biocides sector can exchange views and give input in the ongoing debates. The European Biocidal Products Forum (EBPF) currently comprises more than 60 companies plus affiliated trade associations representing the industry that places a wide range of biocidal products on the market for the benefit of EU citizens. The objective of EBPF is primarily to act as a spokesman for the biocide business community at Union level. The Forum also provides an opportunity for its members to exchange views on regulatory and technical issues relating to active substances evaluation and biocidal product authorisation. In 2010, EBPF established its Sustainable Use Working Group with the objective of identifying, promoting, and improving existing good practice initiatives across the biocides industry in Europe, and initiating further guidance to advocate the responsible use of biocidal products.
    [Show full text]
  • Modelling Biocide and Herbicide Concentrations in Catchments of The
    Hydrol. Earth Syst. Sci. Discuss., https://doi.org/10.5194/hess-2017-628 Manuscript under review for journal Hydrol. Earth Syst. Sci. Discussion started: 2 November 2017 c Author(s) 2017. CC BY 4.0 License. Modelling biocide and herbicide concentrations in catchments of the Rhine basin Andreas Moser1, Devon Wemyss1#, Ruth Scheidegger1, Fabrizio Fenicia1, Mark Honti2, Christian 1 Stamm 5 1Eawag – Swiss Federal Institute of Aquatic Science and Technology, Dübendorf, 8600, Switzerland 2MTA-BME Water Research Group, Hungarian Academy of Sciences, Budapest, 1111, Hungary #current address: ZHAW School of Management and Law, Winterthur, 8400, Switzerland Correspondence to: Christian Stamm ([email protected]) 10 Abstract. Impairment of water quality by organic micropollutants such as pesticides, pharmaceuticals or household chemicals is a problem in many catchments worldwide. These chemicals originate from different urban and agricultural usages and are transferred to surface waters from point or diffuse sources by a number of transport pathways. The quantification of this form of pollution in streams is challenging and especially demanding for diffuse pollution due to the high spatio-temporal concentration dynamics, which requires large sampling and analytical efforts to obtain representative 15 data on the actual water quality. Models can also be used to predict information to which degree streams are affected by these pollutants. However, spatially distributed modeling of water quality is challenging for a number of reasons. Key issues are the lack of such models that incorporate both urban and agricultural sources of organic micropollutants, the large number of parameters to be estimated 20 for many available water quality models, and the difficulty to transfer parameter estimates from calibration sites to areas where predictions are needed.
    [Show full text]
  • Triameen® Y12D – High Performance, Broad Spectrum Biocide
    Thannhausen, Germany, December 19, 2019 Thannhausen, Germany, | Volume 145 Volume | 12/19 vegan silk ® How can silk be vegan? Triameen Y12D – SEPAWA High Performance, congress 12 event report 2019 english Broad Spectrum Biocide home care for Disinfection and sensors High Performance, Broad Spectrum Biocide High-acyl Gellan Gum as a Functional for Disinfection and Preservation Polyacrylate Substitute in Emulsions Preservation skin care Cosmetic Peeling Formulations: Skin- & Environment-friendly Breaking New Ground in the Exploration on Skin Microbiome Biotechnological Active Ingredient, Protecting Skin Microbiota R. Borgmann-Strahsen SOFW Journal 12/19 | Volume 145 | Thannhausen, Germany, December 19, 2019 home care | safety Triameen® Y12D - High Performance, Broad Spectrum Biocide for Disinfection and Preservation R. Borgmann-Strahsen Introduction Control of harmful microorganisms is important in many application fields to ensure human and animal welfare and product integrity. The trend to more sustainable products/pro- cesses like use of natural based raw materials, reduction of Fig. 1 Molecular structure of Triameen® Y12D. solvents and increasing recycling of industrial water enhance the risk of microbial deterioration. Hence biocides play an important role in safeguarding our current standard of living plications. The molecular structure of Triameen® Y12D is shown and realizing a more sustainable future. in Fig. 1. As can be seen it has the shape of a “Y” with primary In Europe the making available on the market and use of bio- amine groups (blue circles) at the end of the 2 propyl groups and a cidal products is regulated by the Biocidal Products Regulation tertiary amine group (black circle) at the cross-point. (BPR, Regulation (EU) No 528/2012).
    [Show full text]
  • Environmental Health Criteria 242
    INTERNATIONAL PROGRAMME ON CHEMICAL SAFETY Environmental Health Criteria 242 DERMAL EXPOSURE IOMC INTER-ORGANIZATION PROGRAMME FOR THE SOUND MANAGEMENT OF CHEMICALS A cooperative agreement among FAO, ILO, UNDP, UNEP, UNIDO, UNITAR, WHO, World Bank and OECD This report contains the collective views of an international group of experts and does not necessarily represent the decisions or the stated policy of the World Health Organization The International Programme on Chemical Safety (IPCS) was established in 1980. The overall objec- tives of the IPCS are to establish the scientific basis for assessment of the risk to human health and the environment from exposure to chemicals, through international peer review processes, as a prerequi- site for the promotion of chemical safety, and to provide technical assistance in strengthening national capacities for the sound management of chemicals. This publication was developed in the IOMC context. The contents do not necessarily reflect the views or stated policies of individual IOMC Participating Organizations. The Inter-Organization Programme for the Sound Management of Chemicals (IOMC) was established in 1995 following recommendations made by the 1992 UN Conference on Environment and Development to strengthen cooperation and increase international coordination in the field of chemical safety. The Participating Organizations are: FAO, ILO, UNDP, UNEP, UNIDO, UNITAR, WHO, World Bank and OECD. The purpose of the IOMC is to promote coordination of the policies and activities pursued by the Participating Organizations, jointly or separately, to achieve the sound management of chemicals in relation to human health and the environment. WHO Library Cataloguing-in-Publication Data Dermal exposure. (Environmental health criteria ; 242) 1.Hazardous Substances - poisoning.
    [Show full text]
  • Obtaining a Biocide Registration for an Advanced Material
    Obtaining a Biocide Registration for an Advanced Material So you think you’ve got something to beat COVID-19, Influenza or other pandemic-causing organisms? Some advanced materials are being evaluated to mitigate the impacts of COVID-19 and other pathogens such as influenza, SARS, MRSA etc. These pathogens include viruses, bacteria and fungi, which are included in a group known as microbes. The intent of some anticipated applications of advanced materials is to kill or control these pathogens. If this is true for you, then… This means you have created an antimicrobial pesticide Among many of the potential uses for advanced materials is as antimicrobial pesticides, sometimes referred to as biocides. This is one of the three classes of pesticides considered by US EPA under the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA). The other two classes (Biopesticides and Conventional pesticides) will not be discussed here. Not all microbes are pathogens. Pathogens are distinguished from other microbes in that they are known to cause diseases such as those caused by COVID-19 and the flu virus. Due to the impact they can have on public health, chemicals used to control pathogens get special attention in the pesticide registration process. You need to prove your product is effective against each target organism There are many types of pathogens and individual biocides are not always effective on all types. Therefore, testing is required to prove that a biocide is effective against each targeted pathogen. For example, the testing required to demonstrate the efficacy of a biocide against COVID-19 needs to be done even if efficacy has already been demonstrated against influenza virus.
    [Show full text]
  • Modelling Biocide and Herbicide Concentrations in Catchments of the Rhine Basin
    Hydrol. Earth Syst. Sci., 22, 4229–4249, 2018 https://doi.org/10.5194/hess-22-4229-2018 © Author(s) 2018. This work is distributed under the Creative Commons Attribution 4.0 License. Modelling biocide and herbicide concentrations in catchments of the Rhine basin Andreas Moser1, Devon Wemyss1,a, Ruth Scheidegger1, Fabrizio Fenicia1, Mark Honti2, and Christian Stamm1 1Eawag – Swiss Federal Institute of Aquatic Science and Technology, Dübendorf, 8600, Switzerland 2MTA-BME Water Research Group, Hungarian Academy of Sciences, Budapest, 1111, Hungary acurrent address: ZHAW School of Management and Law, Winterthur, 8400, Switzerland Correspondence: Christian Stamm ([email protected]) Received: 23 October 2017 – Discussion started: 2 November 2017 Revised: 15 May 2018 – Accepted: 14 July 2018 – Published: 10 August 2018 Abstract. Impairment of water quality by organic microp- ing was explicitly considered by coupling the iWaQa to the ollutants such as pesticides, pharmaceuticals or household AQUASIM model. chemicals is a problem in many catchments worldwide. The model was calibrated with datasets from three differ- These chemicals originate from different urban and agricul- ent small catchments (0.5–24.6 km2/ for three agricultural tural usages and are transferred to surface waters from point herbicides (isoproturon, S-metolachlor, terbuthylazine) and or diffuse sources by a number of transport pathways. The two urban biocides (carbendazim, diuron). Subsequently, it quantification of this form of pollution in streams is challeng- was validated for herbicides and biocides in Switzerland for ing and especially demanding for diffuse pollution due to the different years on 12 catchments of much larger size (31– high spatio-temporal concentration dynamics, which require 35 899 km2/ and for herbicides for the entire Rhine basin up- large sampling and analytical efforts to obtain representative stream of the Dutch–German border (160 000 km2/ without data on the actual water quality.
    [Show full text]
  • Pesticides and Human Health a Resource for Health Care Professionals
    Pesticides and Human Health A Resource for Health Care Professionals Principal Author: Gina Solomon, MD, MPH Senior Scientist, Natural Resources Defense Council Assistant Clinical Professor of Medicine, University of California, San Francisco Co-authors: O.A. Ogunseitan, PhD, MPH Associate Professor Department of Environmental Analysis and Design School of Social Ecology, University of California, Irvine Jan Kirsch, MD, MPH Assistant Clinical Professor of Medicine University of California, San Francisco Dr. Solomon is the principal author of the resource kit. Dr. Ogunseitan provided the initial research and outline, and Dr. Kirsch wrote much of the section on cancer and pesticides. The Introduction and Policy sections were written and edited by staff of Physicians for Social Responsibility–Los Angeles Chapter and California for Pesticide Reform (CPR) in consultation with CPR members. Reviewers: Rupali Das, MD Katherine Forrest, MD Harvey Karp, MD Jan Kirsch, MD, MPH Mike Lim Mark Miller, MD, MPH Marion Moses, MD Carol Mullen, PhD The opinions expressed in this report are those of the authors and do not necessarily reflect the views of our reviewers. Acknowledgments This medical briefing kit would not have been possible without the thoughtful contributions of many physicians and others. In addition to the reviewers on the previous page, Martha Dina Arguello, Jonathan Parfrey, Robert Gould, MD and Art Fisher, MD provided guidance for the kit’s organization and substance. Among those who provided valuable information and participated in helpful discussions were Diane Estrin, Catherine Porter (Women’s Cancer Resource Center); Barbara Brenner (Breast Cancer Action); Ellen Hickey, Susan Kegley (Pesticide Action Network); Joan Clayburgh, Kelly Campbell (Californians for Pesticide Reform); Alice Fisher and Jonathan Kaplan.
    [Show full text]